GLP-1 Injection Site Rotation Guide (Wegovy, Ozempic, Mounjaro, Zepbound)

Complete guide to GLP-1 injection site rotation for Wegovy, Ozempic, Mounjaro, and Zepbound. Includes official prescribing sources and how to automate rotation with Dosio.

By Dosio Editorial TeamUpdated

If you're using Wegovy®, Ozempic®, Mounjaro®, or Zepbound®, proper injection site rotation is part of the official administration guidance — not just a good habit.

This guide pulls together official advice from the FDA, medical best practices, and practical tips — including how Dosio can track your rotation for you automatically.

All rotation guidance in this article is drawn directly from FDA-approved prescribing information and peer-reviewed injection technique literature. See source links throughout.

Official Injection Sites for GLP-1 Medications

According to their FDA-approved prescribing information, GLP-1 medications — semaglutide (Wegovy, Ozempic) and tirzepatide (Mounjaro, Zepbound) — are administered as injections just under the skin (subcutaneous) in three areas:

  • Abdomen — avoid the 2 inches (5 cm) directly around the navel
  • Thigh — outer/front thigh
  • Upper arm — back of the upper arm

All four FDA labels (Ozempic1, Zepbound2, Mounjaro3, Wegovy4) explicitly state that patients should rotate injection sites with each dose.

Why Injection Site Rotation Matters

1. Reducing the Risk of Lipohypertrophy

Repeated injections in the same spot can cause lipohypertrophy, a medical term for fatty lumps or thickened areas that form just under your skin. While this is most common in people who use insulin, injection-technique guidance recommends rotating injection spots.5

2. Preventing Local Injection Site Reactions

FDA labels for semaglutide and tirzepatide report injection-site reactions among possible adverse effects. Following the instruction to rotate sites also avoids repeatedly using the same area.1234

3. Supporting Consistent Results

Injecting repeatedly into an area that has become hard or lumpy may affect absorption. Rotation guidance is intended to support appropriate injection technique.5

A practical, structured 6-zone rotation covers all approved sites:

  1. Left abdomen
  2. Right abdomen
  3. Left thigh
  4. Right thigh
  5. Left upper arm
  6. Right upper arm

Within each region, aim to move at least 1 inch (2.5 cm) from the previous injection point. This approach aligns with injection technique recommendations from the ADA and the Mayo Clinic Proceedings guidelines referenced above.

Common Rotation Mistakes

  • Injecting in the exact same spot every week
  • Only occasionally switching sides
  • Not tracking injection history over time
  • Injecting into hardened or irritated tissue

These patterns can lead to skin issues and may make your medication work less consistently.

How to Automate Injection Site Tracking with Dosio

Manually remembering your last injection zone across months of weekly therapy is unreliable. The Dosio app provides structured rotation support:

  • Set up your Wegovy, Ozempic, Mounjaro, or Zepbound schedule
  • Enable automatic injection site rotation
  • See your recommended next injection zone before each dose
  • Visually track last-used and recently-used areas

This helps you implement FDA-recommended rotation principles without relying on memory or manual tracking.

Ready for a GLP-1 week that feels less random?

Use Dosio to notice the patterns behind side effects, appetite shifts, schedule changes, and progress.

Download on the App StoreGet it on Google Play

Important Legal & Medical Disclaimer

Not Medical Advice This article is provided solely for educational purposes. Always consult your healthcare provider regarding injection technique, site selection, and any concerns about your medication.

Follow Official Instructions
Always follow the official prescribing information and Instructions for Use (IFU) provided by Novo Nordisk (Ozempic/Wegovy) or Eli Lilly (Mounjaro/Zepbound) included with your medication packaging.

Sources

  1. FDA. Ozempic prescribing information and Instructions for Use, revised November 2024. 2

  2. Eli Lilly. Zepbound US prescribing information. 2

  3. Eli Lilly. Mounjaro US prescribing information. 2

  4. FDA. Wegovy prescribing information and Instructions for Use, revised June 2026. 2

  5. Frid AH, Hirsch L, Menchior AR, et al. New insulin injection recommendations for patients with diabetes. Mayo Clinic Proceedings. 2016;91(9):1234-1255. 2

Continue with related Dosio resources